Literature DB >> 24122182

IV thrombolysis and renal function.

Henrik Gensicke1, Sanne M Zinkstok, Yvo B Roos, David J Seiffge, Peter Ringleb, Ville Artto, Jukka Putaala, Elena Haapaniemi, Didier Leys, Régis Bordet, Patrik Michel, Céline Odier, Jörg Berrouschot, Marcel Arnold, Mirjam R Heldner, Andrea Zini, Guido Bigliardi, Visnja Padjen, Nils Peters, Alessandro Pezzini, Christian Schindler, Hakan Sarikaya, Leo H Bonati, Turgut Tatlisumak, Philippe A Lyrer, Paul J Nederkoorn, Stefan T Engelter.   

Abstract

OBJECTIVE: To investigate the association of renal impairment on functional outcome and complications in stroke patients treated with IV thrombolysis (IVT).
METHODS: In this observational study, we compared the estimated glomerular filtration rate (GFR) with poor 3-month outcome (modified Rankin Scale scores 3-6), death, and symptomatic intracranial hemorrhage (sICH) based on the criteria of the European Cooperative Acute Stroke Study II trial. Unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. Patients without IVT treatment served as a comparison group.
RESULTS: Among 4,780 IVT-treated patients, 1,217 (25.5%) had a low GFR (<60 mL/min/1.73 m(2)). A GFR decrease by 10 mL/min/1.73 m(2) increased the risk of poor outcome (OR [95% CI]): (ORunadjusted 1.20 [1.17-1.24]; ORadjusted 1.05 [1.01-1.09]), death (ORunadjusted 1.33 [1.28-1.38]; ORadjusted 1.18 [1.11-1.249]), and sICH (ORunadjusted 1.15 [1.01-1.22]; ORadjusted 1.11 [1.04-1.20]). Low GFR was independently associated with poor 3-month outcome (ORadjusted 1.32 [1.10-1.58]), death (ORadjusted 1.73 [1.39-2.14]), and sICH (ORadjusted 1.64 [1.21-2.23]) compared with normal GFR (60-120 mL/min/1.73 m(2)). Low GFR (ORadjusted 1.64 [1.21-2.23]) and stroke severity (ORadjusted 1.05 [1.03-1.07]) independently determined sICH. Compared with patients who did not receive IVT, treatment with IVT in patients with low GFR was associated with poor outcome (ORadjusted 1.79 [1.41-2.25]), and with favorable outcome in those with normal GFR (ORadjusted 0.77 [0.63-0.94]).
CONCLUSION: Renal function significantly modified outcome and complication rates in IVT-treated stroke patients. Lower GFR might be a better risk indicator for sICH than age. A decrease of GFR by 10 mL/min/1.73 m(2) seems to have a similar impact on the risk of death or sICH as a 1-point-higher NIH Stroke Scale score measuring stroke severity.

Entities:  

Mesh:

Year:  2013        PMID: 24122182     DOI: 10.1212/01.wnl.0000435550.83200.9e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

Review 1.  Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial.

Authors:  Peter R Sinnaeve; Thierry Danays; Kris Bogaerts; Frans Van de Werf; Paul W Armstrong
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

2.  Elevated Plasma Homocysteine Level Increased the Risk of Early Renal Impairment in Acute Ischemic Stroke Patients.

Authors:  Jingjuan Chen; Guode Li; Zuohang Xu; Chengguo Zhang; Yukai Wang; Haiqun Xie; Yan Shao; Lingmei Peng; Jiancong Lu; Dahua Yuan
Journal:  Cell Mol Neurobiol       Date:  2017-03-08       Impact factor: 5.046

Review 3.  Treatment of Central Nervous System Complications of Renal Dialysis and Transplantation.

Authors:  Samer Dahdaleh; Paresh Malhotra
Journal:  Curr Treat Options Neurol       Date:  2019-03-11       Impact factor: 3.598

Review 4.  Stroke and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Management Across Kidney Disease Stages.

Authors:  Taimur Dad; Daniel E Weiner
Journal:  Semin Nephrol       Date:  2015-07       Impact factor: 5.299

5.  Dynamic Changes in the Estimated Glomerular Filtration Rate Predict All-Cause Mortality After Intravenous Thrombolysis in Stroke Patients.

Authors:  Jijun Shi; Yuanyuan Liu; Yiteng Liu; Huihui Liu; Jiaping Xu; Xia Zhang; Shoujiang You; Yongjun Cao
Journal:  Neurotox Res       Date:  2018-10-17       Impact factor: 3.911

Review 6.  Neurologic Complications of Chronic Kidney Disease.

Authors:  Kavitha Vellanki; Vinod K Bansal
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 5.081

7.  Thrombolysis in chinese ischemic stroke patients with renal dysfunction.

Authors:  Wai Ting Lo; Chi Yuen Cheung; Chung Ki Li; Ka Foon Chau; Wing Chi Fong
Journal:  Interv Neurol       Date:  2015-03

8.  Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke.

Authors:  David J Seiffge; Christopher Traenka; Alexandros Polymeris; Lisa Hert; Urs Fisch; Nils Peters; Gian Marco De Marchis; Raphael Guzman; Christian H Nickel; Philipp A Lyrer; Leo H Bonati; Dimitrios Tsakiris; Stefan Engelter
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

9.  Effect of haemoglobin levels on outcome in intravenous thrombolysis-treated stroke patients.

Authors:  Valerian L Altersberger; Lars Kellert; Abdulaziz S Al Sultan; Nicolas Martinez-Majander; Christian Hametner; Ashraf Eskandari; Mirjam R Heldner; Sophie A van den Berg; Andrea Zini; Visnja Padjen; Georg Kägi; Alessandro Pezzini; Alexandros Polymeris; Gian M DeMarchis; Marjaana Tiainen; Silja Räty; Stefania Nannoni; Simon Jung; Thomas P Zonneveld; Stefania Maffei; Leo Bonati; Philippe Lyrer; Gerli Sibolt; Peter A Ringleb; Marcel Arnold; Patrik Michel; Sami Curtze; Paul J Nederkoorn; Stefan T Engelter; Henrik Gensicke
Journal:  Eur Stroke J       Date:  2019-11-13

10.  European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.

Authors:  Eivind Berge; William Whiteley; Heinrich Audebert; Gian Marco De Marchis; Ana Catarina Fonseca; Chiara Padiglioni; Natalia Pérez de la Ossa; Daniel Strbian; Georgios Tsivgoulis; Guillaume Turc
Journal:  Eur Stroke J       Date:  2021-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.